Keyphrases
Roux-en-Y Gastric Bypass
100%
Verapamil
100%
Liraglutide
100%
Sitagliptin
100%
Acarbose
100%
Post-bariatric Hypoglycemia
100%
Pasireotide
100%
Hypoglycemia
30%
Hyperglycemia
30%
Glucose Level
20%
Continuous Glucose Monitoring
20%
Treatment Duration
20%
C-peptide Levels
10%
Baseline Period
10%
Glycemic Variability
10%
Glucagon-like
10%
Monitoring Period
10%
Meal Tolerance Test
10%
Reduced Time
10%
Randomized Crossover Study
10%
Insulin Peptides
10%
Glucose Values
10%
Treatment Effect
10%
Stabilizing Effect
10%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoglycemia
100%
Pasireotide
100%
Liraglutide
100%
Acarbose
100%
Sitagliptin
100%
Verapamil
100%
Hyperglycemia
30%
Scanning Electron Microscopy
10%
Glucagon-Like Peptide-1
10%
C Peptide
10%
Agricultural and Biological Sciences
Liraglutide
100%
Acarbose
100%
Hyperglycemia
30%
Cross-over Studies
10%
Scanning Electron Microscopy
10%
C-Peptide
10%
Glucagon-Like Peptide-1
10%